Moreover, a study by Huang et al. demonstrated that the decreased expression of SELENBP1 could lead to a higher GPX1 activity and reduced HIF-1α expression in hepatocellular carcinoma. This evidence concerns the gene SELENBP1 and hepatocellular carcinoma.